FindTrial
Sign In

Powder for solution for injection

DRUG2 trials

Sponsors

Ipsen Innovation, Stichting Amsterdam UMC

Conditions

Glabellar frown rhytides (wrinkles).Upper limb spasticity after stroke or traumatic brain injury

Phase 1

An Integrated Phase I/II, Multicentre, Double-Blind, Randomised, Dysport and Placebo Controlled, Dose-Escalation and Dose-Finding Study to Evaluate the Safety and Efficacy of IPN10200 in the treatment of Adult Upper Limb Spasticity Followed by an Open-label Extension Period
RecruitingCTIS2023-507202-14-00
Ipsen InnovationUpper limb spasticity after stroke or traumatic brain injury
Start: 2021-04-29Target: 298Updated: 2026-01-19

Phase 4

Head-to-Head Comparison of the Efficacy and Safety of All Commercially Available Botulinum Neurotoxin Type A Products for the Treatment of Glabellar Rhytides: A Multicenter, Triple-Blind, Randomized Controlled Trial
Not yet recruitingCTIS2024-516865-35-01
Stichting Amsterdam UMCGlabellar frown rhytides (wrinkles).
Target: 390Updated: 2025-09-30
Head-to-Head Comparison of the Efficacy and Safety of All Commercially Available Botulinum Neurotoxin Type A Products for the Treatment of Glabellar Rhytides: A Multicenter, Triple-Blind, Randomized Controlled Trial
Not yet recruitingCTIS2024-516865-35-01
Stichting Amsterdam UMCGlabellar frown rhytides (wrinkles).
Target: 390Updated: 2025-09-30